WOBURN, MA / ACCESSWIRE / August 9, 2024 / Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the three and six months ended June 30, 2024 on Wednesday, August 14, 2024. The results will be released after the market close on Wednesday, Aug 14 and the company will host a conference call on Thursday, August 15 at 10:00am Eastern Time.

Conference Call and Webcast Information

Event	Biofrontera Inc. Second Quarter 2024 Financial Results and Business Update Conference Call
Date	Thursday, August 15, 2024
Time	10:00am ET
Conference Call	1-877-877-1275 (U.S.) 1-412-858-5202 (international)
Webcast	https://event.choruscall.com/mediaframe/webcast.html?webcastid=bU2HFqrt

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts:

Investor Relations
Andrew Barwicki
1-516-662-9461
ir@bfri.com

SOURCE: Biofrontera Inc.

View the original press release on accesswire.com

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024